RxDoctor Payments Data

Andrew Rackham, PA

Surgical · Henderson, NVNPI 1831556190

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $26,268 of the $34,205 with a category attached, or 76.8%. It is spread thinly across 34 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. Among surgical clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$34,205in general payments, 2019–2025

Across 1,042 payments — averaging $32.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$6K
  • Incyte Corporation$4K
  • Johnson & Johnson$4K
  • UCB, Inc.$3K
  • Galderma Laboratories, L.p.$2K
  • Lilly USA, LLC$2K
  • plus $14K from 28 others

What the payments were for

  • Consulting fees$6,26018%
  • Speaking & faculty fees$8753%
  • Food & beverage$26,26877%
  • Education$8022%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,205 in reported general payments places this provider in the 95th percentile of 91 surgical providers in Nevada.

See all surgical providers in Nevada

Medicare billing

Part B allowed, 2024
$4,265
Medicare patients
22
Services billed
46

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab13$49,981
Ketoconazole89$1,512
Clobetasol Propionate33$1,385
Fluorouracil14$977
Glycopyrrolate13$877
Triamcinolone Acetonide103$720
Doxycycline Monohydrate43$720
Doxycycline Hyclate22$479
Hydrocortisone60$283
Ciclopirox14$263
Methylprednisolone23$131
Mupirocin20$121

Paid to pharmacies, not to this prescriber.

Other surgical in Henderson

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →